EU AI Act use-case guide · Last verified 2026-01-15High risk

EU AI Act for AI clinical-trial matching in Healthcare & Medical Technology

Trial-matching AI sits at the edge of clinical decision-making and may be high-risk under Annex III §1 depending on deployment context.

Preliminary risk score 67/100Annex III, §1Preliminary summary · Not legal advice
AI clinical trial matchingpatient trial enrolment AItrial eligibility AIGDPR clinical research AIclinical trial matching algorithm

Risk level

AI clinical-trial matching maps to a high-risk Annex III category, so the obligations below apply in full.

Annex III anchor

Annex III, §1

Score basis

A preliminary 67/100 based on the type of decision the system influences and how it is deployed in Healthcare & Medical Technology.

Provider obligations

What the provider (developer) must do

Art. 10

Data governance for trial criteria and patient data

EUR-Lex
Art. 13

Transparency of matching criteria

EUR-Lex

Deployer obligations

What you must do as the deployer

Art. 14

Clinician confirms eligibility before enrolment

EUR-Lex
Art. 26

Document consent process for trial referrals

EUR-Lex

Deployment

How AI clinical-trial matching shows up in Healthcare & Medical Technology

Typical contexts

Hospital trial recruitmentDirect-to-patient trial matching portals

Signals it's in play

  • Trial eligibility
  • Patient-trial matching
  • Inclusion criteria scanning

Recommendations

  • Clinician confirmation step
  • Refresh trial criteria regularly
  • Demographic inclusion audits

Watch-outs

  • Outdated trial criteria
  • Bias toward well-documented patients
  • Misinterpretation of endpoints

FAQ

EU AI Act questions about AI clinical-trial matching

Is AI clinical-trial matching high-risk under the EU AI Act?

AI clinical-trial matching maps to Annex III, §1, which the EU AI Act treats as high-risk. In practice it is assessed as High risk, and the obligations below apply to providers and deployers.

Which EU AI Act articles apply to AI clinical-trial matching?

The obligations that typically apply are Art. 10 — data governance for trial criteria and patient data; Art. 13 — transparency of matching criteria; Art. 14 — clinician confirms eligibility before enrolment; Art. 26 — document consent process for trial referrals. Providers (developers) carry the technical duties; deployers (operators) carry the use, oversight, and transparency duties.

Who is responsible — the provider or the deployer of AI clinical-trial matching?

Both. Providers owe the technical obligations such as Art. 10, Art. 13. Deployers owe Art. 14, Art. 26. The split matters for procurement and vendor agreements in Healthcare & Medical Technology.

What should you watch out for with AI clinical-trial matching?

Common failure modes include: Outdated trial criteria; Bias toward well-documented patients; Misinterpretation of endpoints. Mitigations typically start with Clinician confirmation step and Refresh trial criteria regularly.

Where does AI clinical-trial matching typically appear in Healthcare & Medical Technology?

Typical deployment contexts include Hospital trial recruitment and Direct-to-patient trial matching portals. Before deploying, confirm whether the specific use triggers the high-risk obligations listed above.

Sources

Citations & further reading

Related

More AI use cases in Healthcare & Medical Technology

Limited risk38/100

Customer support chatbot

Automates customer conversations and support triage.

Read the guide
High risk91/100

Medical triage AI

Supports triage, diagnosis, or prioritization in healthcare settings.

Read the guide
Prohibited risk96/100

Biometric identification

Identifies or verifies people using biometric characteristics.

Read the guide
High risk60/100

Biometric access control (workforce)

Employee or patient biometric authentication for premises or systems.

Read the guide
Limited risk47/100

AI on-call staff rostering

Allocates on-call shifts to clinical or operational staff based on demand/availability.

Read the guide
High risk93/100

AI medical image analysis

Analyses radiology/pathology imaging for diagnostic decision support.

Read the guide
High risk95/100

AI surgical robot assistant

Provides real-time guidance or autonomous sub-steps during surgery.

Read the guide
High risk83/100

Continuous patient monitoring AI

Continuously monitors inpatient vitals and raises early-warning scores.

Read the guide
High risk89/100

AI clinical decision support

Recommends diagnosis or treatment paths for clinicians (distinct from triage).

Read the guide
High risk72/100

AI insurance claim triage

Routes or prioritises claims for fast-track, manual review, or SIU escalation.

Read the guide
High risk78/100

AI content moderation

AI that flags, removes, or ranks user-generated content.

Read the guide
Minimal risk18/100

AI retail demand forecasting

Forecasts demand to drive inventory and procurement decisions.

Read the guide
High risk94/100

AI emergency call prioritisation

Scores and prioritises inbound emergency calls for first-responder dispatch.

Read the guide
Limited risk46/100

AI vendor credentialing

Onboarding AI that scores vendor documents, KYB data, and risk signals.

Read the guide
Limited risk35/100

AI document summarisation

Generates concise summaries of long regulatory or contractual documents.

Read the guide

Explore

More industry guides

Describe your exact system, get a personalised read

The guide above is a general baseline for AI clinical-trial matching. The free Risk Scanner maps your specific implementation and surfaces hidden compliance blind spots.

Open the Risk Scanner

Preliminary EU AI Act clarity summary. Not legal advice.